Global Acute Ischemic Stroke Therapeutics Market Report 2024: Size, Drivers, And Top Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
How is the Acute Ischemic Stroke Therapeutics Market Expected to Expand from 2024 to 2033?
The acute ischemic stroke therapeutics market will increase from $8.47 billion in 2023 to $9.24 billion in 2024 at a CAGR of 9.0%. This growth is attributed to a rising patient count, an aging population, increasing obesity rates, higher prevalence of ischemic strokes, and growing hypertension cases.
The acute ischemic stroke therapeutics market is anticipated to reach $13.17 billion in 2028, at a CAGR of 9.3%. Drivers include increased online pharmacy use, cardiovascular diseases, cholesterol levels, and ischemic stroke prevalence. Emerging trends feature AI and machine learning in neurology, advanced diagnostics, and technological innovations.
Claim Your Free Sample of the Global Acute Ischemic Stroke Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19265&type=smp
What Influences Are Propelling the acute ischemic stroke therapeutics Market Forward?
The acute ischemic stroke therapeutics market is expected to grow due to the rising prevalence of hypertension. Hypertension, or high blood pressure, is a condition where blood pressure remains elevated, increasing the risk of heart disease and stroke. The aging population and rising obesity rates are major contributors to the growing incidence of hypertension. Acute ischemic stroke therapeutics help manage hypertension-induced complications, such as stroke, by preventing further damage. The National Health Service England reports that around 30% of adults in the US have hypertension, with 15% being untreated, and the prevalence increases with age. This growing hypertension rate is driving the growth of the acute ischemic stroke therapeutics market.
What Key Segments Exist Within the Acute Ischemic Stroke Therapeutics Market?
1) By Type: Thrombolytic Therapeutics, Antihypertensive Therapeutics, Antiplatelet Therapeutics, Anticoagulants
2) By Route Of Administration: Oral, Parenteral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Hospitals, Ambulatory Surgical Center, Diagnostic Centers
What Trends Are Coming to the Forefront in the 4 Market?
Companies in the acute ischemic stroke therapeutics market are advancing medical technologies like exosome-based therapy to improve treatment effectiveness and patient outcomes. Exosome-based therapy uses extracellular vesicles to aid in treating neurological conditions. For example, in January 2024, Aruna Bio, a US-based developer, received FDA clearance for its investigational new drug application for AB126, the first exosome-based therapy for acute ischemic stroke. This therapy, derived from neural stem cells, has shown promising results in preclinical studies, including anti-inflammatory and neuroprotective effects.
Order Now for Fast Delivery of Your Acute Ischemic Stroke Therapeutics Market Report!
What Regions Are Leading the Charge in the Acute Ischemic Stroke Therapeutics Market?
North America was the largest region in the acute ischemic stroke therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Acute Ischemic Stroke Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the acute ischemic stroke therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Acute Ischemic Stroke Therapeutics Market Include
1. Acute Ischemic Stroke Therapeutics Market Executive Summary
2. Acute Ischemic Stroke Therapeutics Market Segments
3. Acute Ischemic Stroke Therapeutics Market Size And Template Market Growth Rate
4. Key Acute Ischemic Stroke Therapeutics Market Trends
5. Major Acute Ischemic Stroke Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Acute Ischemic Stroke Therapeutics Market
26. Top Acute Ischemic Stroke Therapeutics Companies
27. Acute Ischemic Stroke Therapeutics Market Opportunities And Strategies
28. Acute Ischemic Stroke Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Acute Agitation And Aggression Treatment Global Market Report 2024
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024
Acute Bacterial Skin And Skin Structure Infections Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
